Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-01

Clinical Trial Update: Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Dysport injections and their impact on energy expenditure and walking efficiency in children with cerebral palsy has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Columbia University | Conditions: Cerebral Palsy | Phase 3 | Status: COMPLETED | Results posted: 2022-06-01